DJIA 17,001.22 -38.27 -0.22%
NASDAQ 4,538.55 6.45 0.14%
S&P 500 1,988.40 -3.97 -0.20%
market minute promo

7.91 0.40 (5.33%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SPPI $7.91 5.33%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.48
Previous Close $7.51
Daily Range $7.42 - $7.91
52-Week Range $6.36 - $10.32
Market Cap $519.9M
P/E Ratio -6.01
Dividend (Yield) $0.00 (0.0%)
Volume 883,321
Average Daily Volume 984,145
Current FY EPS -$0.68





Spectrum Pharmaceuticals, Inc. (SPPI) Description

A biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other critical health challenges for which there are few other treatment options. Website:

News & Commentary Rss Feed

A Bad Day for Spectrum Pharmaceuticals' Good News

Spectrum gets a drug approved, and then the share price drops.

Why Spectrum Fell on Beleodaq Approval but Will Rocket on Melphalan Approval

Spectrum Pharmaceuticals (SPPI) Posts Strong Earnings in Q2 - Analyst Blog

Spectrum Pharmaceuticals (SPPI) Posts Strong Earnings in Q2 - Analyst Blog

H.C. Wainwright & Co. Sees Significant Upside Ahead For Spectrum Pharmaceuticals

Spectrum Pharmaceuticals: Key Drug Fusilev May Face Generic Competition Soon

Spectrum Pharmaceuticals Gains U.S. Approval of Beleodaq - Analyst Blog

Why Spectrum Pharmaceuticals (SPPI) Stock Is Higher This Morning

Monday’s Top Biotech Stories: Spectrum, Bristol-Myers Squibb, GSK, and Theravance

Spectrum, Bristol-Myers Squibb, GSK, and Theravance are the top biotech stocks to watch this morning.

This Week in Biotech: Allergan Three-Peats in a Bad Way While Agenus Impresses

An early FDA approval, an inhaled therapy being turned away by regulators for a third time, and three positive clinical updates are this week's top biotech stories.

Spectrum Pharmaceuticals Shares Up 5% Following FDA Accelerated Approval For Beleodaq (SPPI)

See More SPPI News...

SPPI's Top Competitors

SPPI $7.91 (5.33%)
Current stock: SPPI
NVS $88.95 (0.00%)
Current stock: NVS
RHHBY $36.32 (-0.33%)
Current stock: RHHBY
PFE $28.92 (0.35%)
Current stock: PFE